MediciNova granted Notice of Allowance for MN-001 patent by USPTO
MediciNova (MNOV) has received a Notice of Allowance from the USPTO for a pending patent application for MN-001 – Tipelukast – to ...
The Bakersfield Californian11 天
MediciNova Receives Notice of Allowance from United States Patent and Trademark Office for ...
MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange ...